Role of Ezetimibe in Lipid-Lowering and Cardiovascular Disease Prevention
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Role of Ezetimibe in Lipid-Lowering and Cardiovascular Disease Prevention
Authors
Keywords
LDL, Cholesterol, Vytorin, Ezetimibe, LDL hypothesis
Journal
Current Atherosclerosis Reports
Volume 17, Issue 12, Pages -
Publisher
Springer Nature
Online
2015-10-22
DOI
10.1007/s11883-015-0550-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- New Hope for Lipid-Lowering Beyond Statins: Effect of IMPROVE-IT on Understanding and Implementation of Atherosclerosis Prevention
- (2015) Todd J. Anderson CANADIAN JOURNAL OF CARDIOLOGY
- Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
- (2015) Christopher P. Cannon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evaluating cardiovascular event reduction with ezetimibe as an adjunct to simvastatin in 18,144 patients after acute coronary syndromes: Final baseline characteristics of the IMPROVE-IT study population
- (2014) Michael A. Blazing et al. AMERICAN HEART JOURNAL
- Hypertriglyceridemia: a too long unfairly neglected major cardiovascular risk factor
- (2014) Alexander Tenenbaum et al. Cardiovascular Diabetology
- High-potency statin and ezetimibe use and mortality in survivors of an acute myocardial infarction: a population-based study
- (2014) Maheshwar Pauriah et al. HEART
- Inactivating Mutations in NPC1L1 and Protection from Coronary Heart Disease
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
- (2013) Neil J. Stone et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- A Pragmatic View of the New Cholesterol Treatment Guidelines
- (2013) John F. Keaney et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Ezetimibe on Major Atherosclerotic Disease Events and All-Cause Mortality
- (2012) Sami Hayek et al. AMERICAN JOURNAL OF CARDIOLOGY
- Lipid-altering efficacy of ezetimibe plus statin and statin monotherapy and identification of factors associated with treatment response: A pooled analysis of over 21,000 subjects from 27 clinical trials
- (2012) Doralisa Morrone et al. ATHEROSCLEROSIS
- Niemann-Pick C1-Like 1 (NPC1L1) Protein in Intestinal and Hepatic Cholesterol Transport
- (2011) Lin Jia et al. Annual Review of Physiology
- The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
- (2011) Colin Baigent et al. LANCET
- The role of serum non-cholesterol sterols as surrogate markers of absolute cholesterol synthesis and absorption
- (2011) T.A. Miettinen et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Observed and Predicted Reduction of Ischemic Cardiovascular Events in the Simvastatin and Ezetimibe in Aortic Stenosis Trial
- (2010) Ingar Holme et al. AMERICAN JOURNAL OF CARDIOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started